Aviva (AV) Receives Under Review Rating from Shore Capital

Shore Capital restated their under review rating on shares of Aviva (LON:AV) in a report released on Wednesday.

Several other research firms have also weighed in on AV. Citigroup reiterated a buy rating and set a GBX 499 ($6.52) target price on shares of Aviva in a report on Wednesday, October 31st. UBS Group reiterated a buy rating and set a GBX 535 ($6.99) target price (down from GBX 575 ($7.51)) on shares of Aviva in a report on Tuesday, October 16th. Finally, Barclays reduced their target price on Aviva from GBX 610 ($7.97) to GBX 550 ($7.19) and set an overweight rating on the stock in a report on Tuesday, November 20th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and an average target price of GBX 559.69 ($7.31).

Shares of Aviva stock opened at GBX 384.40 ($5.02) on Wednesday. Aviva has a 12 month low of GBX 482.20 ($6.30) and a 12 month high of GBX 550 ($7.19).

In other news, insider Andrew Briggs purchased 25,000 shares of the business’s stock in a transaction dated Wednesday, November 7th. The shares were bought at an average cost of GBX 423 ($5.53) per share, for a total transaction of £105,750 ($138,181.11). Also, insider Belen Romana Garcia purchased 846 shares of the business’s stock in a transaction dated Thursday, September 27th. The stock was purchased at an average price of GBX 497 ($6.49) per share, for a total transaction of £4,204.62 ($5,494.08). Over the last quarter, insiders have acquired 25,913 shares of company stock worth $11,025,292.

Aviva Company Profile

Aviva plc provides various insurance and savings products primarily in the United Kingdom, rest of Europe, Canada, and Asia. The company offers life insurance, long term health and accident insurance, pension, and annuity products; and lifetime mortgage products. It also provides insurance cover to individuals, and small and medium-sized businesses for risks associated primarily with motor vehicles, property, and medical expenses, as well as liabilities, such as employers' and professional indemnity liabilities.

Further Reading: Why is insider trading harmful?

Analyst Recommendations for Aviva (LON:AV)

Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply